Designing inhalable metal organic frameworks for pulmonary tuberculosis treatment and theragnosticsviaspray drying
- 29 September 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (87) , 13339-13342
Abstract
Inhalable metal organic framework (MOF) aerosols have been developed via spray drying as a therapy for multi-drug resistant (MDR) tuberculosis (TB). The CuPOA2 (pyrazinoate acid) MOFs can be tailored to exhibit a respirable mass median aerodynamic diameter (MMAD) of 2.6 μm. This method is repeated to manufacture Gd0.1Cu0.9(POA)2 MOFs for inhalable theragnostics.Keywords
This publication has 69 references indexed in Scilit:
- A spray-drying strategy for synthesis of nanoscale metal–organic frameworks and their assembly into hollow superstructuresNature Chemistry, 2013
- Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-AnalysesAntimicrobial Agents and Chemotherapy, 2011
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosisScience, 2011
- Copper resistance is essential for virulence of Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2011
- Inhaled drug therapy for treatment of tuberculosisTuberculosis, 2011
- Dry Powder PA-824 Aerosols for Treatment of Tuberculosis in Guinea PigsAntimicrobial Agents and Chemotherapy, 2010
- Role of Particle Size in Phagocytosis of Polymeric MicrospheresPharmaceutical Research, 2008
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007
- Rational Design of MOFs Constructed from Modified Aromatic Amino AcidsChemistry – A European Journal, 2007
- Inhaled Large Porous Particles of Capreomycin for Treatment of Tuberculosis in a Guinea Pig ModelAntimicrobial Agents and Chemotherapy, 2007